Home
RA Capital Nexus Fund III, Director: Mineralys Therapeutics MLYS Buy · Filed 23/02/16
Trade details
- Type
- Insider buy
- Amount
- $2,105,600
- Shares · price
- 131,600 sh · $16.00 a share
- Held after
- 1,867,229 sh
- Trade date
- 23/02/14
- Filed
- 23/02/16
- Days to filing
- 2 days
11 insiders bought this week
- Insiders buying this week
- 11 insiders
- Holding change
- +7.6%
Mineralys Therapeutics trades, last 26 weeks
What else happened in Mineralys Therapeutics around then
Filed or reported within 30 days of the trade day · 23/01/15~23/03/16RA Capital Nexus Fund III's recent trades
- RA Capital Nexus Fund III
Planned saleSepterna
Planned saleSepterna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$3.4M
391,019 sh
$3.4M
Filed 06/16
Traded 06/12
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$1.1M
124,893 sh
$1.1M
Filed 06/16
Traded 06/16
